The National Institute of Cardiology, Warsaw, Poland.
Europace. 2010 Sep;12(9):1245-50. doi: 10.1093/europace/euq263. Epub 2010 Jul 21.
Young implantable cardioverter-defibrillator (ICD) recipients present a high rate of inappropriate interventions. Some of them are caused by suboptimal pre-discharge programming of the device. There are conflicting data as regards antitachycardia pacing (ATP) effectiveness in children and young adults. We report our experience with ICD programming and a rate of complications during a 10 year follow-up.
We analysed the use and effectiveness of ATP and complications rate in 63 patients aged 6-21 years. Antitachycardia pacing (burst or ramp) was programmed ON in 14 patients (22%), 49 patients (78%) had only ventricular fibrillation (VF) therapy when discharged after implantation. The incidence of effective vs. ineffective or harmful ATP therapy: 5% of patients vs. 19% of patients differed significantly (P < 0.05). Fourteen patients (22%) received > or =1 appropriate shock(s) for ventricular tachycardia/VF and 17 patients (27%) had one or multiple inappropriate therapy (IT). Inappropriate therapy resulted from T-wave over-sensing (nine patients), sinus tachycardia (three patients), fast atrial fibrillation (five patients), and lead insulation disruption (1%). Reprogramming of the device eliminated IT in all cases. There were 13 (21%) surgical complications. Serious psychological sequelae developed in 27 (43%) patients. There was one death during the follow-up period.
Antitachycardia pacing therapy is rarely effective and often harmful in young ICD recipients. In most patients, programming ICD for only VF therapy is sufficient. Routine pre-discharge programming against inappropriate interventions (especially T-wave over-sensing) helps to reduce the incidence of discharges during the follow-up. The incidence of complications and inappropriate therapies is high in young ICD recipients and affects 50% of patients.
年轻的植入式心脏复律除颤器 (ICD) 受者发生不适当干预的比率较高。其中一些是由于设备的出院前程控不佳引起的。关于儿童和年轻成人的抗心动过速起搏 (ATP) 效果存在相互矛盾的数据。我们报告了我们在 ICD 编程方面的经验以及 10 年随访期间的并发症发生率。
我们分析了 63 名年龄在 6-21 岁的患者的 ATP 使用情况和有效性以及并发症发生率。14 名患者(22%)程控 ATP 为开启,49 名患者(78%)植入后出院时仅具有心室颤动 (VF) 治疗。有效 ATP 治疗与无效或有害 ATP 治疗的发生率:5%的患者与 19%的患者有显著差异(P < 0.05)。14 名患者(22%)因室性心动过速/VF 接受了>或=1 次适当的电击,17 名患者(27%)发生了 1 次或多次不适当的治疗(IT)。不适当的治疗是由 T 波过感知(9 名患者)、窦性心动过速(3 名患者)、快速心房颤动(5 名患者)和导联绝缘破坏(1 名患者)引起的。所有病例均通过重新编程设备消除了 IT。有 13 例(21%)手术并发症。27 名患者(43%)出现严重心理后遗症。随访期间有 1 例死亡。
抗心动过速起搏治疗在年轻的 ICD 受者中很少有效,而且常常是有害的。在大多数患者中,仅对 VF 治疗进行 ICD 编程就足够了。常规进行出院前程控以防止不适当干预(特别是 T 波过感知)有助于降低随访期间的放电发生率。年轻的 ICD 受者并发症和不适当治疗的发生率较高,影响 50%的患者。